Professional Documents
Culture Documents
Images
Preeclampsia
Read More
Blood pressure
Protein - urine
Diabetes
Hypertension
Kidney disease
Eclampsia
Premature infant
Preeclampsia is high blood pressure and protein in the urine that develops after the 20th week of
pregnancy.
Causes
• Autoimmune disorders
• Blood vessel problems
• Diet
• Genes
• First pregnancy
• Multiple pregnancy (twins or more)
• Obesity
• Older than age 35
• Past history of diabetes, high blood pressure, or kidney disease
Symptoms
• Headaches
• Swelling of the hands and face (edema)
• Weight gain
o More than 2 pounds per week
o Sudden weight gain over 1 - 2 days
Note: Some swelling of the feet and ankles is considered normal with pregnancy.
• Abdominal pain
• Agitation
• Decreased urine output
• Nausea and vomiting
• Vision changes
Treatment
The only way to cure preeclampsia is to deliver the baby. However, if that delivery would be
very early (premature), the disease can be managed by bed rest, close monitoring, and delivery as
soon as the fetus has a good chance of surviving outside the womb. Sometimes, medicines are
prescribed to lower the mother's blood pressure.
The pregnant mother is usually admitted to the hospital, but some women may be allowed to stay
at home with careful monitoring of their blood pressure, urine, and weight, and the baby.
Ideally, the condition is managed until the baby can be delivered after the 37th week of
pregnancy.
• Abdominal pain
• Abnormal biophysical profile (a test to monitor the health of the fetus)
• Abnormal liver function tests
• Diastolic blood pressure greater than 100 mmHg consistently for a 24-hour period, or any
confirmed reading over 110 mmHg
• Eclampsia
• Failure of the fetus to grow
• Fluid in lungs (pulmonary edema)
• HELLP syndrome
• Increase in the level of creatinine in the blood
• Low platelet count (thrombocytopenia)
• Low urine production or severe protein in the urine, suggesting decline in kidney function
• Persistent or severe headache
Delivery is the treatment of choice for women with severe preeclampsia who are between 34 - 40
weeks pregnant.
For those who are less than 24 weeks pregnant, inducing labor is recommended, although the
chance that the fetus will survive is very small.
Pregnancies between weeks 24 and 34 are considered a "gray zone." Prolonging a pregnancy has
been shown to lead to problems for the mother in most cases. Infant death also can occur. The
medical team and parents may decide to delay delivery to allow the fetus to develop.
Treatment during 24 - 34 weeks includes giving the mother steroid injections to help tspeed up
the development of the baby's organs (including the lungs). The mother and baby are closely
monitored for complications.
When labor and delivery are induced, the mother will be given medication to prevent seizures
and to keep blood pressure under control. The decision to have a vaginal delivery versus
cesarean section is based on the health of the mother, the baby's ability to tolerate labor, and
other factors.
Outlook (Prognosis)
Death of the mother from preeclampsia is rare in the U.S. The infant's risk of death generally
decreases as the pregnancy continues.
A woman with a history of preeclampsia is at risk for the condition again during future
pregnancies.
Women who have high blood pressure problems during more than one pregnancy have an
increased risk for high blood pressure when they get older.
Possible Complications
Preeclampsia can develop into eclampsia if the mother has seizures. Complications can occur if
the baby is delivered prematurely.
Call your health care provider if you have symptoms of preeclampsia during your pregnancy.
Prevention
Although there is no known way to prevent preeclampsia, it is important for all pregnant women
to start prenatal care early and continue it through the pregnancy. This allows the health care
provider to find and treat conditions such as preeclampsia early.
Alternative Names
Pregnancy-Induced Hypertension
Return to top
PIH is more common in a woman's first pregnancy and in women whose mothers or
sisters had PIH. The risk of PIH is higher in women carrying multiple babies, in
teenage mothers and in women older than age 40. Other women at risk include
those who had high blood pressure or kidney disease before they became pregnant.
The cause of PIH isn't known.
Return to top
Not necessarily. If your doctor sees that your blood pressure is high, he or she will
watch you closely for changes that could mean you have PIH. In addition to high
blood pressure, women who have PIH also have excessive swelling. They may also
have protein in their urine. Many women with high blood pressure during pregnancy
don't have protein in their urine or extreme swelling, and don't get PIH.
Return to top
Does swelling mean I have PIH?
Swelling alone doesn't necessarily mean you have PIH. Some swelling is normal
during pregnancy. For example, your rings or shoes might become too tight.
Swelling is more serious if it doesn't go away after resting, if it's very obvious in
your face and hands, or if it's a rapid weight gain of more than 5 pounds in a week.
Return to top
No one test diagnoses PIH. Your blood pressure will be checked during each doctor's
visit. A big rise in your blood pressure can be an early sign that you might have PIH.
A urine test can tell if there is protein in your urine. Your doctor may order certain
blood tests, which may show if you have PIH. If you have signs of PIH, your doctor
may want to see you at least once a week and possibly every day.
Return to top
PIH can prevent the placenta (which gives air and food to your baby) from getting
enough blood. If the placenta doesn't get enough blood, your baby gets less air and
food. This can cause low birth weight and other problems for the baby.
Most women who have PIH still deliver healthy babies. A few develop a condition
called eclampsia (PIH with seizures), which is very serious for the mother and baby,
or other serious problems. Fortunately, PIH is usually detected early in women who
get regular prenatal care, and most problems can be prevented.
Return to top
If you have PIH, delivery of the baby is the best way to protect both you and your
baby. This isn't always possible, because it may be too early for the baby to live
outside of the womb.
If delivery isn't possible because it's too early in your pregnancy, steps can be taken
to manage the PIH until the baby can be delivered. These steps include making your
blood pressure drop, with bed-rest or medicines, and keeping a close eye on you
and your baby. In some cases, hospitalization may be necessary.
One way to control high blood pressure when you're not pregnant is to cut the
amount of salt you eat. This isn't a good idea if you have high blood pressure
during pregnancy. Your body needs salt to keep up the flow of fluid in your body,
so you need a normal intake of salt. Your doctor will tell you how much salt to eat
each day and how much water you should drink each day.
Your doctor might tell you to take aspirin or extra calcium to prevent PIH. Your
doctor might also tell you to lie on your left side while you are resting. This will
improve blood flow and take weight off your large blood vessels. Many doctors give
magnesium sulfate to their patients during labor and for a few days afterward to
help prevent eclampsia. Talk to your doctor about these things.
Return to top
If my doctor decides to deliver the baby early, will I have to have a cesarean
section?
This is up to your doctor and you. A cesarean section (an operation to deliver the
baby) is more likely if your health or your baby's health is in danger. If things aren't
this serious, your doctor may use medicine (such as oxytocin) to start your labor,
and you can deliver your baby through a vaginal delivery.
Return to top
Symptoms of PIH
If you have any of these symptoms, call your doctor right away:
• Severe headaches
• Vomiting blood
• Excessive swelling of the feet and hands
• Smaller amounts of urine or no urine
• Blood in your urine
• Rapid heartbeat
• Dizziness
• Excessive nausea
• Ringing or buzzing sound in ears
• Excessive vomiting
• Drowsiness
• Fever
• Double vision
• Blurred vision
• Sudden blindness
• Pain in the abdomen (tummy)
Pre-eclampsia
Pre-eclampsia
ICD-9 642.4-642.7
DiseasesDB 10494
MedlinePlus 000898
MeSH [1]
Pre-eclampsia may develop from 20 weeks gestation (it is considered early onset before 32
weeks, which is associated with increased morbidity) and its progress differs among patients;
most cases are diagnosed pre-term. Apart from Caesarean section, or induction of labor, and
therefore delivery of the placenta, there is no known cure. It may also occur up to six weeks post-
partum. It is the most common of the dangerous pregnancy complications; it may affect both the
mother and the fetus.[1]
Contents
[hide]
• 1 Diagnosis
• 2 Epidemiology
• 3 Causes
• 4 Pathogenesis
• 5 Differential diagnosis
• 6 Complications
• 7 Treatment and prevention
o 7.1 Magnesium sulfate
o 7.2 Dietary and nutritional factors
o 7.3 Aspirin supplementation
o 7.4 Exercise
o 7.5 Exposure to partner's semen
o 7.6 Administration of immune factors
• 8 References
• 9 External links
[edit] Diagnosis
Pre-eclampsia is diagnosed when a pregnant woman develops high blood pressure (two separate
readings taken at least 4 hours apart of 140/90 or more) and 300 mg of protein in a 24-hour urine
sample (proteinuria). A rise in baseline BP of 30 systolic or 15 diastolic, while not meeting the
absolute criteria of 140/90 is still considered important to note but no longer diagnostic.
Swelling, or edema, (especially in the hands and face) was originally considered an important
sign for a diagnosis of pre-eclampsia, but in current medical practice only hypertension and
proteinuria are necessary for a diagnosis. However, pitting edema (unusual swelling, particularly
of the hands, feet, or face, notable by leaving an indentation when pressed on) can be significant,
and should be reported to a health care provider.
Although eclampsia is potentially fatal, pre-eclampsia is often asymptomatic, hence its detection
depends on signs or investigations. Nonetheless, one symptom is crucially important because it is
so often misinterpreted. The epigastric pain, which reflects hepatic involvement and is typical of
the HELLP syndrome, may easily be confused with heartburn, a very common problem of
pregnancy. However, it is not burning in quality, does not spread upwards towards the throat, is
associated with hepatic tenderness, may radiate through to the back, and is not relieved by giving
antacids. It is often very severe, described by sufferers as the worst pain that they have ever
experienced. Affected women are not uncommonly referred to general surgeons as suffering
from an acute abdomen, for example acute cholecystitis.
In general, none of the signs of pre-eclampsia is specific; even convulsions in pregnancy are
more likely to have causes other than eclampsia in modern practice. Diagnosis, therefore,
depends on finding a coincidence of several pre-eclamptic features, the final proof being their
regression after delivery.
Some women develop high blood pressure without the proteinuria (protein in urine); this is
called Pregnancy-induced hypertension (PIH) or gestational hypertension. Both pre-eclampsia
and PIH are regarded as very serious conditions and require careful monitoring of mother and
baby.
[edit] Epidemiology
Pre-eclampsia occurs in as many as 10% of pregnancies, usually in the second or third trimester,
and after the 32nd week. Some women will experience pre-eclampsia as early as 20 weeks,
though this is rare. It is much more common in women who are pregnant for the first time,[2] and
its frequency drops significantly in second pregnancies. While change of paternity in a
subsequent pregnancy is now thought to lower risk except in those with a family history of
hypertensive pregnancy,[3] since increasing maternal age raises risk[4] it has been difficult to
evaluate how significant paternity change actually is and studies are providing conflicting data
on this point.
Pre-eclampsia is also more common in women who have preexisting hypertension, diabetes,
autoimmune diseases like lupus, various inherited thrombophilias like Factor V Leiden, or renal
disease, in women with a family history of pre-eclampsia, obese women, and in women with a
multiple gestation (twins, triplets, and more). The single most significant risk for developing pre-
eclampsia is having had pre-eclampsia in a previous pregnancy.
Pre-eclampsia may also occur in the immediate post-partum period or up to 6–8 weeks post-
partum. This is referred to as "postpartum pre-eclampsia." The most dangerous time for the
mother is the 24–48 hours postpartum and careful attention should be paid to pre-eclampsia signs
and symptoms.[5]
[edit] Causes
Many theories have attempted to explain why preeclampsia arises, and have linked the syndrome
to the presence of the following:
The current understanding of the syndrome is as a two-stage process, with a highly variable first
stage which predisposes the placenta to hypoxia, followed by the release of soluble factors which
result in many of the other observed phenomena. Many of the older theories can be subsumed
under this umbrella, as the soluble factors have been shown to cause, for example, endothelial
cell injury, altered vascular reactivity, the classic lesion of glomerular endotheliosis, decreased
intravascular volume, inflammation, etc. Underlying maternal susceptibility to the damage is
likely implicated as well.
[edit] Pathogenesis
Although much research into the etiology and mechanism of pre-eclampsia has taken place, its
exact pathogenesis remains uncertain. Some studies support notions of inadequate blood supply
to the placenta making it release particular hormones or chemical agents that, in mothers
predisposed to the condition, leads to damage of the endothelium (lining of blood vessels),
alterations in metabolism, inflammation, and other possible reactions.[1]
Some studies suggest that hypoxia resulting from inadequate perfusion upregulates sFlt-1, a
VEGF and PlGF antagonist, leading to a damaged maternal endothelium and restriction of
placental growth.[11] In addition, endoglin, a TGF-beta antagonist, is elevated in pregnant women
who develop preeclampsia.[12] Soluble endoglin is likely upregulated by the placenta in response
to an upregulation of cell-surface endoglin produced by the maternal immune system, although
there is also the potential that sEng is produced by the maternal endothelium. Levels of both sFlt-
1 and sEng increase as severity of disease increases, with levels of sEng surpassing levels of
sFlt-1 in HELLP syndrome cases. Recent data indicate that Gadd45a stress signaling regulates
elevated sFlt-1 expression in preeclampsia[13].
Both sFlt-1 and sEng are upregulated in all pregnant women to some extent, supporting the idea
that hypertensive disease in pregnancy is a normal pregnancy adaptation gone awry. As natural
killer cells are intimately involved in placentation and as placentation involves a degree of
maternal tolerance for a foreign placenta which requires maternal resources for its support, it is
not surprising that the maternal immune system might respond more negatively to the arrival of
some placentae under certain circumstances, such as a placenta which is more invasive than
normal. Initial maternal rejection of the placental cytotrophoblasts may be the cause of the
inadequately remodeled spiral arteries in those cases of preeclampsia associated with shallow
implantation, leading to downstream hypoxia and the appearance of maternal symptoms in
response to upregulated sFlt-1 and sEng. (See parent-offspring conflict.)
It has been documented that fetal cells such as fetal erythroblasts as well as cell-free fetal DNA
are increased in the maternal circulation in women who develop preeclampsia. These findings
have given rise to the hypothesis that preeclampsia is a disease process by which a placental
lesion such as hypoxia allows increased fetal material into maternal circulation that leads to an
immune response and endothelial damage ultimately resulting in preeclampsia and eclampsia.
Preeclampsia-eclampsia can mimic and be confused with many other diseases, including chronic
hypertension, chronic renal disease, primary seizure disorders, gallbladder and pancreatic
disease, immune or thrombotic thrombocytopenic purpura, antiphospholipid syndrome and
hemolytic-uremic syndrome. It must always be considered a possibility in any pregnant woman
beyond 20 weeks of gestation. It is particularly difficult to diagnose when preexisting disease
such as hypertension is present.[14]
[edit] Complications
Eclampsia can occur after the onset of pre-eclampsia. Eclampsia, which is a more serious
condition, complicates 1 in 2000 maternities in the United Kingdom and carries a maternal
mortality of 1.8 percent.[15] The HELLP syndrome is more common, probably about 1 in 500
maternities, but may be as dangerous as eclampsia itself. These two major maternal crises can
present unheralded by prodromal signs of pre-eclampsia.
Cerebral hemorrhage is a lesion that can kill women with pre-eclampsia or eclampsia. In that
cerebral hemorrhage is a known complication of severe hypertension in other contexts, it must be
assumed that this is a major predisposing factor in this situation, although this has not been
proved. Adult respiratory distress syndrome appears to have become more common, it is not
known whether this is a consequence of modern methods of respiratory support rather than of the
disease itself.
[edit] Treatment and prevention
The only known treatments for eclampsia or advancing pre-eclampsia are abortion or delivery,
either by induction or Caesarean section. However, post-partum pre-eclampsia may occur up to 6
weeks following delivery even if symptoms were not present during the pregnancy. Post-partum
pre-eclampsia is dangerous to the health of the mother since she may ignore or dismiss
symptoms as simple post-delivery headaches and edema. Hypertension can sometimes be
controlled with anti-hypertensive medication, but any effect this might have on the progress of
the underlying disease is unknown.
Many studies have also suggested the importance of a woman's immunological tolerance to her
baby's father, whose genes are present in the young fetus and its placenta and which may pose a
challenge to her immune system.[6][16] As the theory is further investigated,[17] researchers are
increasingly studying the importance of a woman's continued exposure to her partner's semen as
early as several years before conception. One study published in the American Journal of
Obstetrics and Gynecology involved several hundreds of women and found that "women with a
short period of cohabitation (less than 4 months) who used barrier methods for contraception had
a substantially elevated risk for the development of pre-eclampsia compared with women with
more than 12 months of cohabitation before conception."[18] However, the results from a study
conducted in 2004 show that the theory is still not conclusive. In that study, the researchers
found that after adjustment and stratification, the effect of barrier contraceptive use on the
development of pre-eclampsia had disappeared, with both arms having identical rates of pre-
eclampsia.[19] Although the study has since then been criticized for its subjective adjustment of
data, it remains important because it demonstrates that there is still some contention over the
degree to which failure of tolerance induction can be attributed to prior exposure to the partner's
sperm.
Thrombophilias may be weakly linked to pre-eclampsia. There are no high quality studies to
suggest that blood thinners will prevent pre-eclampsia in thrombophilic women[20].
In some cases, women with preeclampsia or eclampsia can be stabilized temporarily with
magnesium sulfate intravenously to forestall seizures while steroid injections are administered to
promote fetal lung maturation. Magnesium sulfate as a possible treatment was considered at least
as far back as 1955,[21] but only in recent years did its use in the UK replace the use of diazepam
or phenytoin.[22] Evidence for the use of magnesium sulfate came from the international
MAGPIE study.[23] When induced delivery needs to take place before 37 weeks gestation, it is
accepted that there are additional risks to the baby from premature birth that will require
additional monitoring and care.
Studies conducted on the effect of supplementation with antioxidants such as vitamin C and E
found no change in pre-eclampsia rates.[25] However, Drs. Padayatty and Levine with the NIH
criticized the studies for overlooking several key factors that would have been important to the
success of the supplementation. Because plasma ascorbate concentrations were not reported, they
were estimated from known data, and the placebo and treatment groups in the study probably had
similar plasma and tissue ascorbate concentrations. Some of the smaller doses of 1 g per day
would have had little effect on plasma or intracellular ascorbate concentrations,[26] so the studies
should have been conducted with higher dosages of vitamin C in order for there to have been
any beneficial effects.
Low levels of vitamin D may be a risk factor for preeclampsia,[27] and calcium supplementation
in women with low-calcium diets found no change in preeclampsia rates but did find a decrease
in the rate of severe preeclamptic complications.[28] Low selenium status is associated with higher
incidence of pre-eclampsia.[29][30] Some other vitamin may also play a role.[31]
The late Dr. Thomas Brewer, OBGYN, believed in the role that diet can play in contributing to
pre-eclampsia, especially HELLP syndrome. Although Dr. Brewer's approach has been seen as
unconventional by western medicine because there is no evidence for it,[original research?] some
pregnancy practitioners adhere religiously to his recommendations.[citation needed] Women who
previously had pre-eclampsia or HELLP present anecdotes claiming that following Dr. Brewer's
guidelines has allowed them to go on to have healthy pregnancies, even in cases where their
physicians believed their pre-eclampsia could reoccur.[citation needed] Subsequent pregnancies are
known to be at lower risk of pre-eclampsia.[citation needed] The Brewer dietary theory is over 40 years
old but lacks peer-reviewed support; modern research provides no role for diet in placentation or
in tolerance induction.[citation needed]
Aspirin supplementation is still being evaluated as to dosage, timing, and population and may
provide a slight preventative benefit in some women; however, significant research has been
done on aspirin and the results thus far are unimpressive.[32]
[edit] Exercise
Long periods of sexual cohabitation with the same partner fathering a woman's child
significantly decreased her chances of suffering pre-eclampsia.[18] [36] As one early study
described, "although preeclampsia is a disease of first pregnancies, the protective effect of
multiparity is lost with change of partner." [37] The study also concluded that although women
with changing partners are strongly advised to use condoms to prevent sexually transmitted
diseases, "a certain period of sperm exposure within a stable relation, when pregnancy is aimed
for, is associated with protection against preeclampsia."[37]
Several other studies have since investigated the strongly decreased incidence of pre-eclampsia
in women who had received blood transfusions from their partner, those with long, preceding
histories of sex without barrier contraceptives, and in women who had been regularly performing
oral sex,[38][39] with one study concluding that "induction of allogeneic tolerance to the paternal
HLA molecules of the fetus may be crucial. Data collected strongly suggests that exposure, and
especially oral exposure to soluble HLA from semen can lead to transplantation tolerance."[39]
Other studies have investigated the roles of semen in the female reproductive tracts of mice,
showing that "insemination elicits inflammatory changes in female reproductive tissues,"[40]
concluding that the changes "likely lead to immunological priming to paternal antigens or
influence pregnancy outcomes." A similar series of studies confirmed the importance of immune
modulation in female mice through the absorption of specific immune factors in semen,
including TGF-Beta, lack of which is also being investigated as a cause of miscarriage in women
and infertility in men.
According to the theory, the fetus both contain "foreign" proteins from paternal genes, but
regular, preceding and coincident exposure to the father's semen may promote immune
acceptance and subsequent implantation, a process which is significantly supported by as many
as 93 currently identified immune regulating factors in seminal fluid.[6][16]
Having already noted the importance of a woman's immunological tolerance to her baby's
paternal genes, several Dutch reproductive biologists decided to take their research a step further.
Consistent with the fact that human immune systems tolerate things better when they enter the
body via the mouth, the Dutch researchers conducted a series of studies that confirmed a
surprisingly strong correlation between a diminished incidence of pre-eclampsia and a woman's
practice of oral sex, and noted that the protective effects were strongest if she swallowed her
partner's semen.[39][38][41][42][43][44] The researchers concluded that while any exposure to a partner's
semen during sexual activity appears to decrease a woman's chances for the various
immunological disorders that can occur during pregnancy, immunological tolerance could be
most quickly established through oral introduction and gastrointestinal absorption of semen.[39][41]
Recognizing that some of the studies potentially included the presence of confounding factors,
such as the possibility that women who regularly perform oral sex and swallow semen also
engage in more frequent intercourse, the researchers also noted that, either way, "the data still
overwhelmingly supports the main theory" behind all their studies--that repeated exposure to
semen establishes the maternal immunological tolerance necessary for a safe and successful
pregnancy.[36][41]
A team from the University of Adelaide has also investigated to see if men who have fathered
pregnancies which have ended in miscarriage or pre-eclampsia had low seminal levels of critical
immune modulating factors such as TGF-Beta. The team has found that certain men, dubbed
"dangerous males," are several times more likely to father pregnancies that would end in either
preeclampsia or miscarriage.[36] Among other things, most of the "dangerous males" seemed to
lack sufficient levels of the seminal immune factors necessary to induce immunological tolerance
in their partners. [45]
As the theory of immune intolerance as a cause of pre-eclampsia has become accepted, women
who suffer repeated pre-eclampsia, miscarriages, or In Vitro Fertilization failures could
potentially be administered key immune factors such as TGF-beta along with the father's foreign
proteins, possibly either orally, as a sublingual spray, or as a vaginal gel to be applied onto the
vaginal wall before intercourse.[36]
In 2006, researchers at the University of Adelaide developed a gel containing TGF-Beta for use
in human populations.[46] Later, GroPep, the company which was awarded the patent on a TGF-
Beta3 variant, conducted trials where the miscarriage rate was halved in the mice studied.
According to a GroPep news release later published, "a faulty immune response is implicated in
the etiology of as many as 50% of all miscarriages."[47] Their drug, PV903, was "targeted to treat
recurrent miscarriages caused by an abnormal immune response to the foetus, a condition for
which there is no current [drug] treatment." [47] Stage I clinical trials of their vaginal gel were
partly successful, succeeding in establishing the safety of the drug, but failing in their aim of
increasing the number of specific immune cells measured in circulation, the necessary condition
for affecting a desired immunological desensitization.[47][48] The trials were later criticized for
failing to recognize the synergistic effects of a large variety of immune factors naturally present
in seminal fluid, which, acting together and with the localized presence of the foreign paternal
proteins, modulate the female immune response so as to allow for implantation, and then the
subsequent immune acceptance of the (foreign) fetus throughout a successful pregnancy. GroPep
was later acquired by the biotechnology giant, Novozymes. The development of the PV903 drug
has since then been placed on hold.
Preeclampsia
Definition
By Mayo Clinic staff
Preeclampsia is a condition of pregnancy marked by high blood pressure and excess protein in
your urine after 20 weeks of pregnancy. Preeclampsia often causes only modest increases in
blood pressure. Left untreated, however, preeclampsia can lead to serious — even fatal —
complications for both you and your baby.
If you have preeclampsia, the only cure is delivery of your baby. If you're diagnosed with
preeclampsia too early in your pregnancy for delivery to be an option, you and your doctor need
to allow your baby more time to mature, without putting you or your baby at risk of serious
complications.
Symptoms
By Mayo Clinic staff
Preeclampsia can develop gradually but often attacks suddenly, after 20 weeks of pregnancy.
Preeclampsia may range from mild to severe. If your blood pressure was normal before your
pregnancy, signs and symptoms of preeclampsia may include:
Swelling (edema), particularly in your face and hands, often accompanies preeclampsia.
Swelling isn't considered a reliable sign of preeclampsia, however, because it also occurs in
many normal pregnancies.
Because headaches, nausea, and aches and pains are common pregnancy complaints, it's difficult
to know when new symptoms are simply part of being pregnant and when they may indicate a
serious problem — especially if it's your first pregnancy. If you're concerned about your
symptoms, contact your doctor.
Causes
By Mayo Clinic staff
Preeclampsia used to be called toxemia because it was thought to be caused by a toxin in a
pregnant woman's bloodstream. This theory has been discarded, but researchers have yet to
determine what causes preeclampsia. Possible causes may include:
Risk factors
By Mayo Clinic staff
• Having other health conditions. There's some evidence that both urinary
tract infections and periodontal disease during pregnancy are associated with
an increased risk of preeclampsia, which may indicate that antibiotics could
play a role in prevention of preeclampsia. More study is needed.
• Vitamin D insufficiency. There's also some evidence that insufficient
vitamin D intake increases the risk of preeclampsia, and that vitamin D
supplements in early pregnancy could play a role in prevention. More study is
needed.
• High levels of certain proteins. Pregnant women who had high levels of
certain proteins in their blood or urine have been found to be more likely to
develop preeclampsia than are other women. These proteins interfere with
the growth and function of blood vessels — lending evidence to the theory
that preeclampsia is caused by abnormalities in the blood vessels feeding the
placenta. Although more research is needed, the discovery suggests that a
blood or urine test may one day serve as an effective screening tool for
preeclampsia.
Complications
By Mayo Clinic staff
Most women with preeclampsia deliver healthy babies. The more severe your preeclampsia and
the earlier it occurs in your pregnancy, however, the greater the risks for you and your baby.
Preeclampsia may require induced labor and delivery by Caesarian section. Complications of
preeclampsia may include:
Preeclampsia usually shows up during a routine prenatal blood pressure check and urine test. The
diagnosis depends on the presence of high blood pressure and protein in your urine after 20
weeks of pregnancy. Certain markers in your blood and urine may be indications of
preeclampsia. That's why it's essential to seek early and regular prenatal care throughout your
pregnancy.
Additional tests
If you're diagnosed with preeclampsia, your doctor may recommend additional tests, including:
• Blood tests. These can determine how well your liver and kidneys are
functioning and whether your blood has a normal number of platelets — the
cells that help blood clot.
• Prolonged urine collection test. Urine samples taken over at least 12
hours and up to 24 hours can quantify how much protein is being lost in the
urine, an indication of the severity of preeclampsia.
• Fetal ultrasound. Your doctor may also recommend close monitoring of
your baby's growth, typically through ultrasound. This test directs high-
frequency sound waves at the tissues in your abdominal area. These sound
waves bounce off the curves and variations in your body, including your
baby. The sound waves are translated into a pattern of light and dark areas
— creating images of your baby on a monitor that can be recorded
electronically or on film for a look at the inside of your uterus.
• Nonstress test or biophysical profile. These make sure your baby is
getting enough oxygen and nourishment. A nonstress test is a simple
procedure that checks how your baby's heart rate reacts when your baby
moves. Your baby is doing fine if the heart rate increases at least 15 beats a
minute for at least 15 seconds twice in a 20-minute period. A biophysical
profile combines an ultrasound with a nonstress test to provide more
information about your baby's breathing, tone, movement and the volume of
amniotic fluid in your uterus.
Treatments and drugs
By Mayo Clinic staff
The only cure for preeclampsia is delivery. You're at increased risk of seizures, placental
abruption, stroke and possibly severe bleeding until your blood pressure decreases. Of course, if
it's too early in your pregnancy, delivery may not be the best thing for your baby.
If you've had preeclampsia in one or more previous pregnancies, some experts recommend more
frequent prenatal visits than normally recommended for pregnancy. Your doctor may ask you to
come in every two weeks between the 20th and 32nd week of your gestation, and weekly after
that until delivery.
Medications
Your doctor may recommend the following:
Bed rest
If you aren't near the end of your pregnancy and you have a mild case of preeclampsia, your
doctor may recommend bed rest to lower your blood pressure and increase blood flow to your
placenta, giving your baby time to mature. You may need to lie in bed, only sitting and standing
when necessary. Or you may be able to sit on the couch or in bed and strictly limit your
activities. Your doctor may want to see you a few times a week to check your blood pressure,
urine protein levels and your baby's well-being.
If you have more severe preeclampsia, you may need bed rest in the hospital. In the hospital, you
may have regular nonstress tests or biophysical profiles to monitor your baby's well-being and
measure the volume of amniotic fluid. A lack of amniotic fluid is a sign of poor blood supply to
the baby.
Delivery
If you're diagnosed with preeclampsia near the end of your pregnancy, your doctor may
recommend inducing labor right away. The readiness of your cervix — whether it's beginning to
open (dilate), thin (efface) and soften (ripen) — also may be a factor in determining whether or
when labor will be induced.
In more severe cases, it may not be possible to consider your baby's gestational age or the
readiness of your cervix. If it's not possible to wait, your doctor may induce labor or schedule a
C-section earlier in your pregnancy. During delivery, you may be given magnesium sulfate
intravenously to increase uterine blood flow and prevent seizures.
After delivery, expect your blood pressure to return to normal within a few weeks.
Prevention
By Mayo Clinic staff
There's no known way to prevent preeclampsia. Eating less salt or changing your activities
during pregnancy doesn't reduce the risk. The best way to take care of yourself — and your baby
— is to seek early and regular prenatal care. If preeclampsia is detected early, you and your
doctor can work together to prevent complications and make the best choices for you and your
baby.
There's some evidence that taking certain vitamins, such as vitamin D, may lower the risk of
preeclampsia. Ask your doctor what he or she recommends. Don't take anything during
pregnancy without your doctor's approval.